The NDUFB9 gene helps build complex I, one of the cell’s energy making machines inside mitochondria. If this gene does not work properly, cells may struggle to make enough energy, especially in organs with high energy needs such as the brain, muscles, and heart. Rare severe variants in the NDUFB9 gene are linked to mitochondrial complex I deficiency, which can cause developmental delay, low muscle tone, movement problems, seizures, or heart involvement. NDUFB9 is mainly discussed in medical genetics rather than popular culture.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells can use to make molecules or regulate processes in the body. Some genes carry the directions for making proteins, the parts of cells that do the work. Other genes mostly help determine when certain processes happen, where they take place, and how strongly they occur. Together, genes influence how the body develops and functions, and they can shape how you respond to food, stress, or medications. If you want to look into this subject more closely, you can find more in the LearnHub.
Overview
NDUFB9Gene function
What if the gene works
The NDUFB9 gene helps mitochondria, your cells’ energy makers, run complex I, an early step in converting food and oxygen into usable energy. This supports steady function in energy-hungry tissues such as the brain, muscles, and heart.
Risk
What if the gene does not work
Pathogenic variants in the NDUFB9 gene can cause mitochondrial complex I deficiency, often with lactic acidosis, cardiomyopathy, and brain involvement. Milder or more severe variants can affect when symptoms begin and how strongly the condition affects the body.
Treatment
What does that mean for your treatment
No NDUFB9-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the NDUFB9 gene.
Conditions associated with NDUFB9
Gene function
What if the gene works
The NDUFB9 gene helps your mitochondria make usable energy from food. It works as part of complex I, a large protein group in the inner membrane of mitochondria. This is one of the first steps in cellular respiration, the process cells use to power everyday activity. Understanding how the NDUFB9 gene helps mitochondria make energy can make this pathway easier to picture.
The NDUFB9 gene supports complex I as electrons enter the cell’s main energy pathway. This helps your cells start turning fuel from food into a form they can use.
By helping complex I work smoothly, NDUFB9 supports the charge difference across the mitochondrial membrane that drives ATP production. ATP is the cell’s main energy packet for movement, growth, and repair.
One of its main roles is to help keep complex I properly built and steady within mitochondria. This supports reliable day to day energy production in many tissues.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help create normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the NDUFB9 gene can weaken or destabilize a small part of mitochondrial complex I, so cells have more trouble making energy. Some changes sharply reduce how much NDUFB9 protein is made or keep it from fitting into the complex, while milder variants may leave partial activity. This range helps explain how NDUFB9 gene variants affect mitochondrial energy production and why some people develop mitochondrial disease earlier or more severely than others.
How variants are linked to conditions
Pathogenic variants in the NDUFB9 gene cause mitochondrial complex I deficiency, a rare inherited condition and the main disease linked to NDUFB9 gene variants. People with this diagnosis may have symptoms that start in infancy or childhood, often involving developmental delay, low muscle tone, feeding difficulties, seizures, or problems affecting the brain, muscles, or heart. Some may develop a Leigh syndrome pattern, which is a specific form of neurologic mitochondrial disease.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In other situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For NDUFB9, risk is mainly shaped by inherited gene changes rather than lifestyle or everyday exposures. The clearest factor is family history, especially if both biological parents carry a harmful change in the NDUFB9 gene; there is not broadly confirmed evidence that diet, exercise, or other common habits meaningfully change this genetic risk.
Inheritance of NDUFB9 variants
NDUFB9-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one NDUFB9 gene variant from each parent, and the parents are often healthy carriers. When both parents carry a variant in the NDUFB9 gene, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. In families asking how NDUFB9 gene variants are inherited, this is the well-established pattern seen for the condition linked to this gene.
What does my NDUFB9 result mean for my family?
For NDUFB9, the family pattern is usually recessive, which means parents of an affected child are often healthy carriers. Brothers and sisters may also be affected or may be carriers, and other close relatives could be carriers as well. Because of this, family members may wish to discuss genetic testing in the context of the known family result.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the NDUFB9 gene, doctors use genetic testing for NDUFB9 variants, usually on a blood or saliva sample. A lab reads the gene’s DNA, often as part of a mitochondrial disease panel, exome, or genome test, and compares it with known variants.
When should I consider getting a genetic test?
Genetic testing for the NDUFB9 gene may be considered when a child or adult has signs of a rare condition that affects how the body's cells make energy, such as developmental delay, weak muscles, seizures, or brain changes linked to Leigh syndrome, especially if similar problems run in the family. Testing can help confirm whether NDUFB9 is the cause.
A genetic result is only one part of your health story
A genetic result may provide useful information, yet what it can tell you varies with the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment, yet one may get the expected benefit while the other may notice less effect or more side effects because their bodies absorb, break down, or respond to the drug differently. This kind of difference is common and is one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medications. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support more informed, individualized treatment decisions. More about this topic is available in the LearnHub.
Drugs influenced by the NDUFB9 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to medicines. If you have concerns about side effects, new symptoms, or whether a treatment is working as expected, it is best to speak with your doctor.